Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis
NCT ID: NCT00361998
Last Updated: 2007-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
400 participants
INTERVENTIONAL
2006-09-30
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Course Nitrofurantoin for Acute Cystitis
NCT00391651
COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN
NCT06518291
Single Dose Monurol for Treatment of Acute Cystitis
NCT00976963
EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care
NCT05254808
A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department
NCT01749605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NITROFURANTOIN MACROCRYSTALS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Uncomplicated cystitis
Exclusion Criteria
2. Complicated UTI
3. Women with catheter
4. Women with recurrent UTI
5. Pregnancy
6. Diabetes Mellitus
18 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clalit Health Services
OTHER
HaEmek Medical Center, Israel
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raul Raz, M.D.
Role: PRINCIPAL_INVESTIGATOR
Infectious Diseases Unit, HaEmek Medical Center, Afula, Israel
Uzi Milman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Research Unit, Clalit Health Services, Haifa and Western-Galilee District, Israel.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Unit, Clalit Health Services, Haifa and Western Galillee District
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0706
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.